Mount Sinai Oncology will work with patients on a case by case basis to review insurance coverage. Patients can expect a call from the office after booking to discuss these details. The practice will try to accommodate the time selected however the appointment date and time may need to adjusted to better suit the specific patient case. Adilia Hormigo, MD, PhD is Director of the Neuro-Oncology Program for The Mount SinaiHospital and the Mount Sinai Health System, and Associate Professor in the Department of Neurology, Medicine (Division of Hematology-Oncology) and Neurosurgery. She is a neuro-oncologist specializing in the care of patients with primary brain tumors, CNS metastases, and the neurological complications of cancer and its treatment. She employs a multidisciplinary team approach to ensure that patients receive compassionate, comprehensive care. Dr. Hormigo obtained her MD with honors from the University of Lisbon Medical School in Portugal, and her PhD from New York University. She completed residencies in Neurology at the University Hospital of Lisbon Medical School, Portuguese Oncological Institute and New York Presbyterian-Weill Medical College of Cornell University and Memorial Sloan-Kettering Cancer Center. She completed both research and clinical neuro-oncology fellowships under Jerome B. Posner. She served as faculty at Memorial Sloan-Kettering Cancer Center and Cornell University. She trained a number of fellows, many of whom are faculty in leading programs of neuro-oncology in the country and abroad. Her clinical and translational research focuses on new strategies including personalized treatment for patients with brain tumors with emphasis on immunotherapy, developing new biomarkers and studying the microenvironment of brain tumors. Her goal is to achieve the highest level of patient care and clinical excellence. She sees patients at the Ruttenberg Treatment Center of the Tisch Cancer Institute.

Education & experience

Education

Medical School - Universidade de Lisboa Faculdade de Medicina

New York University (PhD)

Universidade De Lisboa, Internship in Neurology

Universidade De Lisboa, Residency in Neurology

Memorial Sloan-Kettering Cancer Center, Fellowship in Neuro-Oncology

NewYork-Presbyterian Hospital / Weill Cornell Medical Center, Residency in Neurology

NewYork-Presbyterian Hospital / Weill Cornell Medical Center, Internship in Internal Medicine

Practice

Mount Sinai Cancer

Affiliation

The Mount Sinai Hospital

Mount Sinai St. Luke’s

Mount Sinai West

Mount Sinai Beth Israel

Certifications

American Board of Psychiatry and Neurology

Neurology (Psychiatry and Neurology)

Awards and publications

2013 Fellow American Neurological Association.

2012 Advanced Techniques in Molecular Neuroscience Cold Spring Harbor Laboratory.

2005 Excellence in Teaching Award for the Neurology Clerkship Weill Medical College of Cornell University.

2003 Resident Award American Academy of Neurology.

Iwamoto FM, Hormigo A. Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma. Frontiers in oncology 2014; 4.

Nael K, Bauer AH, Hormigo A, Lemole M, Germano IM, Puig J, Stea B. Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma. AJR. American journal of roentgenology 2018 Jan; 210(1).

Connelly J, Hormigo A, Mohilie N, Hu J, Chaudhry A, Blondin N. Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement. BMC cancer 2016 11; 16(1).

Rhome R, Fisher R, Hormigo A, Parikh RR. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma. Journal of neuro-oncology 2016 06; 128(2).

Biofarma Portuguese Society of Neurology.